These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 10453230
21. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Noel GJ, Blumer JL, Pichichero ME, Hedrick JA, Schwartz RH, Balis DA, Melkote R, Bagchi P, Arguedas A. Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063 [Abstract] [Full Text] [Related]
22. An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients. Jareoncharsri P, Bunnag C, Fooanant S, Tunsuriyawong P, Voraprayoon S, Srifuengfung S, Dhiraputra C. Rhinology; 2004 Mar; 42(1):23-9. PubMed ID: 15072030 [Abstract] [Full Text] [Related]
23. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Ghaffar F, Muniz LS, Katz K, Reynolds J, Smith JL, Davis P, Friedland IR, McCracken GH. Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764 [Abstract] [Full Text] [Related]
24. Role of sulbactam/ampicillin and sultamicillin in the treatment of bacterial infections of the upper respiratory tract of children. Bluestone CD. APMIS Suppl; 1989 Oct; 5():35-40. PubMed ID: 2660869 [Abstract] [Full Text] [Related]
26. [Systemic antibiotic treatment in routine practice. Exacerbated chronic bronchitis, lower respiratory tract infections in children, acute otitis media, acute sinusitis in children, acute sinusitis in adults]. Agence Française de Securité Sanitaire des Produits de Santé. Rev Pneumol Clin; 2001 Nov; 57(5):323-37. PubMed ID: 11924228 [No Abstract] [Full Text] [Related]
27. [Amoxicillin-clavulanic acid combination in bacterial infections of the upper respiratory tract in childhood. Controlled clinical study]. Boccazzi A, Borzani M, Scotti L. Pediatr Med Chir; 1988 Nov; 10(4):395-400. PubMed ID: 3068633 [Abstract] [Full Text] [Related]
28. Interleukin-1 receptor antagonist as an adjunct in the treatment of Haemophilus influenzae otitis media in the chinchilla. Kerschner JE, Beste DJ, Lynch JB, Fox MC, Kehl KS. Laryngoscope; 2000 Sep; 110(9):1457-61. PubMed ID: 10983942 [Abstract] [Full Text] [Related]
31. Antibiotics for acute rhinosinusitis. Kaiser L, Hirschel B. Arch Intern Med; 2004 Mar 08; 164(5):568; author reply 570. PubMed ID: 15006837 [No Abstract] [Full Text] [Related]
32. Appropriate use of antibiotics for URIs in children: Part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team. Dowell SF, Schwartz B, Phillips WR. Am Fam Physician; 1998 Oct 01; 58(5):1113-8, 1123. PubMed ID: 9787277 [Abstract] [Full Text] [Related]
33. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. Soriano F, Parra A, Cenjor C, Nieto E, García-Calvo G, Giménez MJ, Aguilar L, Ponte C. J Infect Dis; 2000 Feb 01; 181(2):646-52. PubMed ID: 10669350 [Abstract] [Full Text] [Related]
34. Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial. Autret-Leca E, Giraudeau B, Ployet MJ, Jonville-Béra AP. Br J Clin Pharmacol; 2002 Dec 01; 54(6):652-6. PubMed ID: 12492614 [Abstract] [Full Text] [Related]
35. [Role of ciprofloxacin in the treatment of chronic otitis media]. Fontanel JP. Presse Med; 1998 Oct 03; 27(29):1506-8. PubMed ID: 9798472 [No Abstract] [Full Text] [Related]
36. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. J Antimicrob Chemother; 2004 Jan 03; 53 Suppl 1():i3-20. PubMed ID: 14726431 [Abstract] [Full Text] [Related]
37. Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults. Garau J, Twynholm M, Garcia-Mendez E, Siquier B, Rivero A, 557 Clinical Study Group. J Antimicrob Chemother; 2003 Nov 03; 52(5):826-36. PubMed ID: 14563899 [Abstract] [Full Text] [Related]
38. A blind parallel comparative study of the efficacy and safety of rovamycin versus augmentin in the treatment of acute otitis media. Mgbor NC, Umeh RE. West Afr J Med; 2002 Nov 03; 21(2):117-20. PubMed ID: 12403032 [Abstract] [Full Text] [Related]
39. Trends in otitis media treatment failure and relapse. Sox CM, Finkelstein JA, Yin R, Kleinman K, Lieu TA. Pediatrics; 2008 Apr 03; 121(4):674-9. PubMed ID: 18381530 [Abstract] [Full Text] [Related]
40. Comparison of amoxicillin + clavulanate with or without intranasal fluticasone for the treatment of uncomplicated acute rhinosinusitis in children. Wan KS, Wu WF, Chen TC, Wu CS, Hung CW, Chang YS. Minerva Pediatr; 2015 Dec 03; 67(6):489-94. PubMed ID: 26530491 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]